2h
Zacks Investment Research on MSNIs it Apt to Retain HAE Stock in Your Portfolio for Now?Haemonetics Corporation’s HAE impressive Hospital business recovery is poised to drive growth in the upcoming quarters. The robust uptake of the NexSys PCS system bodes well for its long-term growth.
State of Michigan Retirement System decreased its stake in Haemonetics Co. (NYSE:HAE – Free Report) by 2.5% in the 4th ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results